Direct bisulphite conversion of cervical samples for DNA methylation analysis 121 5 1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941-53. 2. Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014; 383(9916): 524-32. 3. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009; 112(2): 293-9. 4. Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer 2019; 121(11): 954-65. 5. Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014; 14(6): 395-405. 6. Bierkens M, Wilting SM, van Wieringen WN, van Kemenade FJ, Bleeker MC, Jordanova ES, et al. Chromosomal profiles of highgrade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer 2012; 131(4): E579-85. 7. De Strooper LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, Snijders PJF, Meijer C, et al. Cervical cancer risk in HPVpositive women after a negative FAM19A4/ miR124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up. Int J Cancer 2018; 143(6): 1541-8. 8. Dick S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, Steenbergen RDM, Meijer C, et al. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis. Gynecol Oncol 2019; 154(2): 368-73. 9. Vink FJ, Lissenberg-Witte BI, Meijer C, Berkhof J, van Kemenade FJ, Siebers AG, et al. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Clin Microbiol Infect 2020. 10. Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study. Int J Cancer 2020. 11. Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology 2013; 38(1): 23-38. 12. Feng L, Lou J. DNA Methylation Analysis. Methods Mol Biol 2019; 1894: 181-227. 13. EZ DNA Methylation(TM) Kit - Instruction manual Version 1.2.6; https://www. zymoresearch.com/collections/ezdna-methylation-kits/products/ez-dnamethylation-kit, Accessed on June 8, 2021. 08-06-2021. https://www.zymoresearch. com/collections/ez-dna-methylation-kits/ products/ez-dna-methylation-kit. 14. QIAsure Methylation Test Instructions for use (handbook) Version 1 (March 2017). https://www.qiagen.com/nl/resources/ resourcedetail?id=d4851ddc-405d-4d93be9a-a343c8576d64&lang=en; Accessed on June 8, 2021. 08-06-2021. 15. Epitect Fast 96 Bisulfite Conversion Handbook (July 2020) https:// www.qiagen.com/us/resources/ resourcedetail?id=96b87a18-4894-432aae20-6c18dfb9ba20&lang=en; Accessed on June 8, 2021. REFERENCES
RkJQdWJsaXNoZXIy MjY0ODMw